Subcutaneous Implantable Cardioverter Defibrillator

DEVICE2 trials

Sponsors

Boston Scientific Corporation, Luigi Sacco University Hospital

Conditions

Cardiac ArrestCardiovascular DiseaseDiabetes MellitusImplantable Cardiac DefibrillatorSudden Cardiac DeathTachycardiaVentricular Arrythmia

Unknown Phase

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

CompletedNCT02787785

Boston Scientific CorporationCardiovascular Disease, Diabetes Mellitus, Tachycardia

Start: 2017-04-17End: 2023-06-30Updated: 2024-08-22

Experience From the Italian S-ICD Registry

Luigi Sacco University HospitalCardiac Arrest, Implantable Cardiac Defibrillator, Sudden Cardiac Death +1

Start: 2020-01-01End: 2022-12-31Target: 500Updated: 2021-04-13

Related Papers

Clinical impact of defibrillation testing in a real‐world S‐ICD population: Data from the ELISIR registry

Journal of Cardiovascular Electrophysiology2020-12-1015 citations